Sfairopoulos, Dimitrios
Liatis, Stavros
Tigas, Stelios
Liberopoulos, Evangelos
Article History
Received: 9 January 2018
Accepted: 14 May 2018
First Online: 12 June 2018
Compliance with ethical standards
:
: DS has no relevant conflict of interest to report. SL has received research support and/or consulting honoraria from Astra-Zeneca, Boehringer-Ingelheim, MSD, Novartis, Novo Nordisk, Sanofi-Aventis, Eli Lilly, and ELPEN. ST has received lecture honoraria or travel grants from, and/or has participated in advisory boards of, Astra-Zeneca, Boehringer-Ingelheim, Eli Lilly, ELPEN, Galenica, MSD, Novartis, Novo Nordisk, and Sanofi-Aventis. EL has participated in educational, research, and advisory activities sponsored by Astra-Zeneca, MSD, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Boehringer-Ingelheim, Novartis, Novo Nordisk, Servier, Galenica, ELPEN, and Valeant.